Revvity Inc. (NYSE:RVTY) Declares $0.07 Quarterly Dividend

Revvity Inc. (NYSE:RVTY) declared a quarterly dividend on Thursday, April 30th. Stockholders of record on Friday, July 17th will be paid a dividend of 0.07 per share on Friday, August 7th. This represents a c) dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th.

Revvity has a payout ratio of 5.1% indicating that its dividend is sufficiently covered by earnings. Analysts expect Revvity to earn $5.99 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 4.7%.

Revvity Stock Down 0.9%

Revvity stock traded down $0.77 during trading hours on Friday, reaching $85.85. The stock had a trading volume of 211,730 shares, compared to its average volume of 1,244,694. Revvity has a 52 week low of $81.22 and a 52 week high of $118.30. The company has a market cap of $9.60 billion, a price-to-earnings ratio of 41.34, a PEG ratio of 1.75 and a beta of 1.13. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.68 and a quick ratio of 1.40. The business’s 50 day moving average price is $90.39 and its 200-day moving average price is $96.74.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. During the same period in the previous year, the company earned $1.42 earnings per share. The business’s revenue for the quarter was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Sell-side analysts anticipate that Revvity will post 5.39 EPS for the current year.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.